NICE is unable to make a recommendation about the use in the NHS of paclitaxel as albumin‑bound nanoparticles with carboplatin for adults with untreated non‑small‑cell lung cancer when potentially curative surgery or radiation therapy or both are unsuitable, because no evidence submission was received from Celgene for the technology.

  • National Institute for Health and Care Excellence (NICE)